COVID-19
PRODUCT SEARCH
REPORTING OF SIDE EFFECTS TO MEDICINES OR VACCINES
NPRA mission
NPRA mission is to safeguard the nation’s health through scientific excellence in the regulatory control of medicinal products and cosmetics.
PELAN ANTIRASUAH NPRA |
Oral Anticoagulants (Apixaban, Dabigatran, Edoxaban, Rivaroxaban and Warfarin): Risk of Atraumatic Splenic Rupture |
List of Renewal Approved Veterinary Products |
Valproate (Sodium Valproate, Valproic Acid): Potential Risks to Offspring Following Paternal Exposure, and Male Infertility |
|
04 Sep 2025; 08:00AM - 05:00PM Bengkel Pengujian Kawalan Kualiti Bahan Mentah Herba Bagi Produk Semulajadi |
20 Nov 2024; 08:30AM - 04:15PM MOPI Training 2024: Good Submission Practice 2.0 for Generic Medicines |
12 Nov 2024; 08:00AM - 05:00PM MOPI Training 2024: Good Distribution Practice for the Regulated Industry |
15 Oct 2024; 08:00AM - 05:00PM MOPI Training 2024: A practical approach to ISO 13485 QMS for medical devices |
25 Sep 2024; 08:00AM - 05:00PM MOPI Training 2024: Contamination Control - How to Develop an Effective Contamination Control Strategy |